Drugs / PD-1 knockout TILs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07035002 | Dec 2024 → Dec 2025 overdue | colorectal cancer | Ruijin Hospital | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PD-1 knockout TILs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07035002 ↗ |
| Action | Inhibit | “gene editing technology to knockout PD-1” NCT07035002 ↗ |
| Modality | Cell therapy | “TIL from tumor tissue of advanced colorectal cancer patients were cultured, modified and expanded in vitro, and then transfused back to the patients after quality control.” NCT07035002 ↗ |
| Route | Other | “transfusing them back to the patient” NCT07035002 ↗ |